Ortho Clinical Diagnostics (OCDX) Tops Q1 EPS by 3c

Ortho Clinical Diagnostics (NASDAQ: OCDX) reported Q1 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $508.21 million.

For earnings history and earnings-related data on Ortho Clinical Diagnostics (OCDX) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• HCA Holdings (HCA) Tops Q2 EPS by 19c ; Offers Guidance
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays